ehealth radio network
The importance of accurate and precise blood volume measurement in heart failure and critical care patients

The importance of accurate and precise blood volume measurement in heart failure and critical care patients

December 23, 2020

 

DXR_Michael_headshot80zvv.png

Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.


Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:

  1. Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
  2. Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
  3. How does BVA-100 allow clinicians to provide better outcomes for their patients?
  4. Are there any recent studies that validate BVA?
  5. Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?

Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.

 

Daxor_Logo_Update_RGB-red_1_88w98.png

 

Website: www.daxor.com

Social Media Links:
Facebook: facebook.com/Daxorcorp 
Linkedin: linkedin.com/company/daxorcorporation 
Twitter: twitter.com/DaxorBVA

The Future of Medical Recalls

The Future of Medical Recalls

December 18, 2020

 

Joan_Melendez_Post72quy.png

 

Joan Melendez, the Founder and President at health-tech startup Xcelrate UDI joins eHealth Radio and the Health News and Technology Channels. Their technology, a medical device barcode scanning solution, identifies and prevents the use of recalled and faulty medical products and devices to improve patient safety at the point of care.


Listen to interview with host Eric Michaels and guest Joan Melendez discuss the following:

  1. What is a Unique Device Identifier, and why has it become so relevant in recent times?
  2. What kind of impact are medical recalls currently having on the healthcare industry and patients?
  3. How could full-scale adoption of your barcode scanning technology change healthcare - for patients and the industry as a whole?
  4. How can technology be better used across healthcare -- for communication, organisation, data storage?
  5. The Closed Loop Automation Solution you’ve partnered on has introduced an electronic patient implant card. How will this benefit patients?

Tip: If you’ve had a medical device implanted or are about to, ask your doctor about how they are ensuring your implants are safe for use and how you will be notified of quality issues should your implants be recalled after they are implanted.


Founder and President Joan Melendez leads the team at Xcelrate UDI. Having been in the healthcare industry since her teens, Joan has become a passionate advocate for the safety of patients and for innovation in healthcare.

Xcelrate UDI is a healthcare technology and consulting services company that leverages the power of UDI (unique device identifier) barcode scanning technology to bridge the information gaps between data sources (provided by manufacturers and the FDA) for medical devices and physical supplies. Their vision? To be the industry’s most trusted partner in advancing UDI adoption to improve compliance with medical devices and reduce patient risk at the point of care.

 

UDI_Black_Logo_Transparent_background88k8c.png

 

Website: www.xcelrateudi.com

Social Media Links:
Facebook: facebook.com/xcelrateudi 
Linkedin: linkedin.com/company/xcelrate-udi 
Instagram: instagram.com/xcelrateudi

Research shows that honey can be effective with respiratory illness

Research shows that honey can be effective with respiratory illness

December 16, 2020

 

Dr_Baljit_Khamba8o91q.png

 

Dr. Baljit Khamba, a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California joins eHealth Radio and the Health News Channel.

Bastyr University is a nonprofit, private university offering doctoral, graduate and undergraduate degrees, with a multidisciplinary curriculum in science-based natural medicine. Recognized globally for its rigorous curriculum and strong research, the 42-year-old University has campuses in Kenmore, Washington, and San Diego, California. Bastyr's international faculty educate future leaders in the natural health arts and sciences, with an emphasis on integrating mind, body, spirit and nature.


Listen to interview with host Eric Michaels and guest Dr. Baljit Khamba discuss the following:

  1. Tell us how you and your colleagues came to this research idea.
  2. What evidence did the research show that honey can be effective with respiratory illness?
  3. Why is your immunity and respiratory health important right now?
  4. How can you incorporate honey into your daily routine to support your immune system?
  5. What are other ways people can boost their immune system?

Dr. Baljit Khamba is a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California. She treats a variety of conditions but has special interest in nutritional approaches to anxiety, stress, depression, focus and attention, memory and cognition. She focuses on providing high quality care addressing the causes of disease and utilizes safe and effective natural treatments. She accepts patients and their families who are motivated to improve their health. Her emphasis is on disease prevention and health promotion through education and empowering her patients to become active participant in the management of their own health.

While completing bachelor and master’s degrees, she worked as a research analyst at the Centre for Addiction and Mental Health (CAMH), where she researched alcohol addiction and anxiety, as well as nutrition and mental health. Dr. Khamba also has experience working in integrative psychiatric clinics, as well as more generalized practice, as well as being involved with research projects at the University of Alberta on natural health product safety in psychiatric patients. Dr. Khamba also maintains a private telemedicine practice.

935b4b7e-2bfd-4462-b9e5-0a63be7e596570ec5153-0fd5-4425-a835-1246927b3b2e.jpg

Websites: https://bastyr.edu | https://bastyrclinic.org

No Cost Covid-19 Antibody Community Testing with Dr. Harrington, MD

No Cost Covid-19 Antibody Community Testing with Dr. Harrington, MD

November 28, 2020

 

GAH_New_1_9t8aq.png

 

Dr. Douglas S. Harrington, MD Fellow of the American Society of Preventive Cardiology, and the American Society of Clinical Pathology, who is an expert in laboratory diagnostic testing joins eHealth Radio and the Health Care and Health News Channels. Dr. Harrington is also the Chairman of the GUARDaHEART Foundation 501(c)3 who is actively partnering with community organizations, nonprofit organizations, businesses, and city officials to provide the community with No-Cost COVID-19 Antibody Tests covered under the CARES Act.


Listen to interview with host Eric Michaels and guest Dr. Douglas S. Harrington discuss the following:

  1. What is GUARDaHEART Foundation’s goal in partnering with the community to provide the SARS-CoV-2 Antibody Test?
  2. What is the difference between a COVID-19 swab test vs and COVID-19 SARS-CoV-2 antibody test?
  3. Who should take the antibody test and what are the benefits of having the test?
  4. What is the difference between IgG and IgM antibodies and how long does it take to develop antibodies?
  5. How long do the antibodies stay in my body?
  6. If my antibody report results positive, am I immune to COVID-19?
  7. What happens if someone tests positive for the COVID-19 Antibodies? Should they be quarantined?
  8. Is it true that the Latin Community and African American Community have the highest rates of COVID? If so, why is that?
  9. What is the correlation of heart disease and coronavirus?
  10. Tell us about the SARS-CoV-2 serology antibody test being provided with a sensitivity of 100% and a specificity of 99.6% based on initial performance evaluations. Is this more reliable than other tests being provided?
  11. Are there natural medicines that aim to help to reduce an individual from getting the virus?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. Heco-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma StudyGroup headed by Dr. Jim Armitage. As President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology,cytogenetic, and anatomic pathology offerings. Dr. Harrington led the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr.Harrington also led the turnaround and reinstatement of theFederal license of Specialty Laboratories, a New York StockExchange company, as CEO and Laboratory Director.

Dr. Harrington has developed patents for an automated method for image analysis of residual cancer cells, a patent covering catalytic heavy metal extraction, and a patent pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer and cardiology,where he has taken a number of new molecular technologies through state and federal regulatory approval, and has been involved in the commercialization of over 200 academic discoveries. He is a member of Phi Beta Kappa, the nation’s most prestigious academic honor society.

Dr. Harrington is the inventor of the PULS Cardiac Test (TM) ,a breakthrough blood test for the detection of the leading cause of heart attacks, and CEO & Laboratory Director ofGlobal Discovery Biosciences. Throughout his career Dr.Harrington has remained a Clinical Professor of Pathology at the USC Keck School of medicine, a published author of numerous peer-reviewed papers, and a sought after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biology, his MD from the University of Colorado HealthSciences Center, and is a board-certified in hematology,anatomic and clinical pathology.

 

GAH_New_1_9t8aq.png

 

Website: www.guardaheart.org

Social Media Links:      
Facebook: facebook.com/Guardaheartfoundation  
Twitter: twitter.com/guardaheartorg

How To Pivot Your Practice During The Pandemic

How To Pivot Your Practice During The Pandemic

October 28, 2020

Patrick_McEneaney6v9f9.png

 

Dr. Patrick McEneaney, Founder and CEO of Northern Illinois Foot & Ankle Specialists joins eHealth Radio and the Foot Health and Health News Channels. Northern Illinois Foot and Ankle physicians, doctors, and surgeons diagnose and treat complex pediatric and adult foot and ankle conditions, providing their patients with the latest in treatment options to maximize outcomes.


Listen to interview with host Eric Michaels and guest Dr. Patrick McEneaney discuss the following:

  1. What are some ways Northern Illinois Foot and Ankle has pivoted or helped during the pandemic?
  2. What were some expectations you had behind expanding to the COVID-19 Lab & Testing Center?
  3. What important information should people know about the Northern Illinois Lab & Testing Centers?
  4. Are there any requirements for testing?
  5. What is the turnaround for testing results?
  6. Next month is Diabetes Awareness month, can you share with us more on why awareness for diabetes is so important?
  7. If you are diabetic, how are your feet impacted?
  8. What are ways you help diabetics manage their symptoms?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Dr. Patrick McEneaney is a board-certified DPM, owner, and CEO of Northern Illinois Foot & Ankle Specialist. Dr. McEneaney has a unique story being a young entrepreneur under 45 y/o with ten clinics and plans to expand, all while still practicing in foot and ankle care during a global pandemic. As the current president of the Illinois Podiatric Medical Association and Medical Director & Principal Investigator of NF&A, he has garnered numerous literature journal publications. His specialties involve advanced reconstructive surgery of foot & ankle dealing with flatfoot reconstruction, post-traumatic injury management, deformity correction, and wound care/limb salvage. Along with experience in diabetes and senior health care.

 

northernllinoisfoota.png

 

Website: https://illinoisfoot.com

Social Media Links:
Facebook: facebook.com/Illinoisfoot 
Instagram: instagram.com/northern_illinois_foot_ankle 
Linkedin: linkedin.com/company/illinoisfoot

AI-Powered Medical Financial Aid Solution Helps Patients Access Care and Health Systems

AI-Powered Medical Financial Aid Solution Helps Patients Access Care and Health Systems

October 17, 2020

ethandavidoff.png

 

Ethan Davidoff, CEO and founder of Atlas Health, the leader in philanthropic reimbursement that empowers health systems with an end-to-end solution for enrolling patients in medical financial aid programs joins eHealth Radio and the Health News and the Health Care Channels.


Listen to interview with host Eric Michaels and guest Ethan Davidoff discuss the following:

  1. Please tell our audiences about Atlas Heath, its goals and who it serves.
  2. Tell us about the Navigator 4.0, and the services and benefits it will provide to health systems and its users.
  3. What are your relationships with healthcare payers and philanthropic relief programs designated to help aid hospital systems during the COVID-19 pandemic?
  4. What benefits can Navigator 4.0 offer to 340B hospital systems who are experiencing the significant rate cuts during these unprecedented times?
  5. Are there any financial risks to employers or hospital systems may be facing right now that Navigator 4.0 is working to solve?
  6. Hospital systems are desperate for any type of aid during the COVID-19 pandemic. What other ways can your services provide relief for hospitals struggling with financial pressures?
  7. How can patients who have lost their jobs and health insurance due to the COVID-19 economic crisis benefit from Atlas' Navigator 4.0 in terms of longevity?
  8. Does Atlas’ Navigator 4.0 plan on providing relief for urgent care or walk-in clinics that receive patients for COVID-19 testing or intervention?
  9. COVID-19 patients often also experience other related illnesses. What other ways can your services provide treatment and ensure patients will be financially and medically protected?
  10. How have you been trying to educate under-served populations on your services? Please describe how Atlas’ Navigator 4.0 will help with the challenges for under-served populations with access to primary care services?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Atlas Health, the leader in philanthropic reimbursement, is improving and saving lives by empowering providers with an end-to-end solution for matching and enrolling patients in medical financial aid programs through its proprietary technology and AI-powered service partnership platform, Atlas Navigator. Patients receive the care they need and providers secure reimbursement for care delivered.


Ethan Davidoff is the Founder & CEO of Atlas Health with over 10 years of healthcare, enterprise software, and cyber security experience. Ethan Davidoff founded Atlas Health in 2017 and maintains the role of CEO. Under his direction, the company has become the leader in philanthropic reimbursement.

Prior to Atlas Health, Davidoff was a founding member of RiskIQ. Serving as Vice President and General Manager of Internet Security, he managed a cross-functional team to grow an emerging business unit with fortune 500 and top technology companies.

Davidoff studied business, entrepreneurship, and software development at the University of California at Berkeley and the London School of Economics.

 

logo_ea1a77d96d620b5f55758b7422817c0d_2x.png

 

Website: https://atlas.health

Linkedin: linkedin.com/company/atlashealth

Focusing on the Unique Medical, Economic and Healthcare Coordination Needs of People with Rare and Orphan Diseases

Focusing on the Unique Medical, Economic and Healthcare Coordination Needs of People with Rare and Orphan Diseases

October 15, 2020

 

Donovan_Quillacdh7.png

 

Donovan Quill, President and CEO of Optime Care, a nationally recognized pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders joins eHealth Radio and the Health News & Health Care Channels.


Listen to interview with host Eric Michaels and guest Donovan Quill discuss the following:

  1. Please tell our audiences about Optime Care, its goals and who it serves.

  2. What is considered a rare or orphan disease?

  3. What is the definition of a specialty pharmaceutical? How many drugs are currently on the market and how many in development?

  4. How does Optime Care ensure that patients get their drugs?

  5. What are your relationships with healthcare payers?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Optime Care, Inc. is a nationally recognized pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our management team has previously partnered in the launch of more than 25 orphan products and consistently implemented the best brand program for the community. Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers.


Donovan Quill entered the world of healthcare after a successful coaching career and teaching at the collegiate level. His personal mission was to help patients who suffer from an orphan disorder that has affected his entire family (Alpha-1 Antitrypsin Deficiency). Donovan became a Patient Advocate for Centric Health Resources and traveled the country raising awareness, improving detection, and providing education to patients and healthcare providers.

Donovan quickly gained recognition among the patient community for his efforts. He was heavily recruited and hand-picked by Alpha-1 Foundation founder John Walsh to become the Foundation’s Director of Detection and Community Outreach. Donovan gained an in-depth knowledge of the inner workings of not-for-profit patient-driven programs while working with the Alpha-1 Foundation. His responsibilities included public policy agendas within government affairs, national targeted detection programs, research projects with “Key Opinion Leaders”, patient educational and marketing programs, fundraising efforts, and serving as a liaison to the drug manufacturers.

After leaving the not-for-profit sector, Donovan developed a new and innovative sales strategy with Talecris Biotherapeutics (now Grifols), which he piloted in a sales territory that had underperformed historically. By emphasizing education, early detection, and awareness, Donovan was able to take a poor performing territory and grow it into one of the top markets in the country in a short period of time. The strategy was so successful that Donovan was asked to work with the Brand Team to launch it throughout the rest of the country.

Donovan’s success in the sales world led to a return to Centric Health Resources (now DLSS), where he worked on their largest piece of business and developed innovative strategies to improve a growing and successful program. Over the next few years, Donovan went from directing a small team of Patient Advocates to Vice President of Patient Services to Senior Vice President of Patient Direct Programs.

Donovan’s experiences with the Alpha-1 Foundation, Centric Health Resources and DLSS have provided him the opportunity to manage all aspects of operations, develop operational plans for product launches/relaunches, improve program effectiveness, manage a large number of employees from pharmacists to nurses to patient support specialists, design infrastructure, create business development opportunities, and play a key role in companywide strategic planning.

Regardless of his position, Donovan has always kept one thing top of mind: “If you take care of the people that matter, the program will always be successful.” Donovan has spent years doing just that for patients, caregivers, healthcare providers, and product manufacturers.

 

Optime_Care_LOGOa7c9a.png

 

Website: optimecare.com

Linkedin: linkedin.com/company/optime-care

Running a Non-Profit Clinic in Times of COVID

Running a Non-Profit Clinic in Times of COVID

September 23, 2020

 

BertaCabrera.jpg

 

Berta Cabrera, Executive Director of the SSJ Health Foundation, a charitable organization providing financial support for the St. John Bosco Clinic, a free clinic serving uninsured and under served children and adults in Miami-Dade County joins eHealth Radio and the Health Care and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Waqaas Al-Siddiq discuss the following:

  1. Tell me a little bit about the St. John Bosco Clinic and the role of the SSJ Health Foundation?
  2. As COVID-19 has affected the world, and SFL has been known as a hot spot, what has been the impact on the clinic?
  3. How has the community and the clinic risen up to meet this challenge?
  4. Looking past COVID-19, what do you think the long-term impacts and best practices will be?
  5. As a non-profit, I’m sure funding is crucial to your success. How can the community support you as you increase your patient load?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

The SSJ Health Foundation is a charitable organization providing financial support for St. John Bosco Clinic, a free clinic serving uninsured and under served children and adults in Miami-Dade County.

Their mission is to provide compassionate and philanthropic support for the health care ministry of the Congregation of the Sisters of St. Joseph of St. Augustine, Florida, to the uninsured and under served in the Miami-Dade community.

 

SSJHealthFoundation.png

 

Website: ssjhealthfoundation.org

Social Media Links:
Facebook: facebook.com/ssjhealthfoundation.org 
Instagram: instagram.com/ssjhealthfoundation

How Telehealth is Transforming the Way We Receive Care

How Telehealth is Transforming the Way We Receive Care

September 1, 2020

 

ArtCooksey_Biz.jpeg

 

Art Cooksey, Founder and CEO of Let’s Talk Interactive, a provider of customizable telehealth solutions including a sophisticated HIPAA-compliant video conferencing platform, kiosks, medical carts, virtual clinics and more joins eHealth Radio and the Health Care & Tele-Health Channels. Their mission is to enable providers to offer care at any time from any location in the world.


Listen to interview with host Eric Michaels and guest Art Cooksey discuss the following:

  1. Tele-health has really taken off since the pandemic hit (demand in the U.S. expected to increase by 64% in the U.S. alone). When did you get involved in Tele-health technology and in your opinion, how is it evolving since COVID-19? What key areas should people look for in a tele-health platform?
  2. How does Let’s Talk Interactive fit into those areas?
  3. Walk us through what a tele-medicine visit is like.
  4. Tell us about the areas where tele-health can be impactful to people - beyond primary care practitioners and hospitals.
  5. What does the future hold for tele-health and tele-medicine? Where will we be using it that we are not today?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

Arthur Cooksey serves as the Chairman and CEO of Let’s Talk Interactive, Inc. (LTI), leading the corporate strategy and development to drive the adoption of LTI’s suite of products and services. He founded the technology platform in 2001 as a way to provide consumers with access to qualified and licensed behavioral health professionals, which he later evolved to customized services and telehealth technology that LTI is known for today.

The platform is having a major impact in the Florida Panhandle region. Championed by Florida’s First Lady Casey DeSantis and her Hope for Healing Initiative, the program placed telehealth kiosks from Let’s Talk Interactive in 63 public schools throughout the region. As a result, more than 60,000 students have access to mental health support.

In addition to collaborating with schools, Arthur continues to lead the growth of LTI into correctional institution programs, working alongside sheriff teams in Franklin County, FL to reduce recidivism through behavioral health support for inmates. He also emphasizes telehealth innovation among political leaders by attending judiciary hearings and White House event including the Summit on Transforming Mental Health Treatment to Combat Homelessness, Violence, and Substance Abuse.

Prior to Let’s Talk Interactive, Arthur held corporate and strategic roles for more than a decade, including leading corporate development with Bank of America Merchant Services. He was selected as a member of Bank of America’s Market President team where he reviewed social, economic and education issues, and sat on a political action committee that supported nonprofits throughout the Charlotte region.

A Charlotte native, Arthur continues to reside in his hometown.

 

62245870_2040317586076598_3817730119414317056_n.jpg

 

Website: www.letstalkinteractive.com

Facebook: facebook.com/LetsTalkInteractive

First-of-its Kind Technology Created to Help Improve the Outcomes of Chronically Ill Patients

First-of-its Kind Technology Created to Help Improve the Outcomes of Chronically Ill Patients

August 28, 2020

Photo_-_Dr_Bob_Monteverdi_SM__2673_FINAL_for_PRINT-PUB_Cropped_Smallest_Jan2017af0hn.jpeg

 

Dr. Bob Monteverdi, Global Healthcare Solutions Leader for Lenovo Health at Lenovo who is an executive and physician with over three decades of experience across business and healthcare joins eHealth Radio and the Technology and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Bob Monteverdi discuss the following:

  1. When we think about bigger picture in healthcare right now, what products does Lenovo have and what do they mean for healthcare providers and patients?
  2. Is Virtual Rounding a solution that will still be relevant after the COVID-19 pandemic has subsided?
  3. So, why Lenovo in the healthcare space?
  4. Recently, Dr. Fauci warned that we might be seeing 100K new cases of COVID-19 each day.
  5. How does tele-health and virtual care help minimize these numbers? What results are you seeing from this type of care?

 

eu_natural_breathe_ads_300x250_8_part_17jx5e.jpg

 

“Dr. Bob” is an executive and physician with three plus decades leading cross-functional business lines, healthcare product management organizations and strategic marketing efforts. His leadership roles have ranged across firms from early stage startups on through major corporate entities that include Thomson Reuters, McKesson, Optum, IBM, and SAS.

During his career he has led numerous efforts in the acute and ambulatory provider markets in addition to driving organizations in the payer, life sciences and pharmacy segments. He is known for his passionate, collaborative and motivational results-driven leadership style, is a graduate of Hofstra University and was in private medical practice in New York State for a decade before embarking on his healthcare information technology career.

At Lenovo, Dr. Bob leads the effort to transform Lenovo Health from a hardware focused entity into providing a broader portfolio of healthcare technology solutions encompassing software and services.

 

Lenovo_LOGO.png

 

Websites: https://www.lenovo.com/us

Social Media Links:
Facebook: https://www.facebook.com/lenovoUS 
Instagram: https://www.instagram.com/lenovous 
Youtube: https://www.youtube.com/user/LenovoVision 
Twitter: https://twitter.com/lenovous

Play this podcast on Podbean App